Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Allergan Plc (AGN)

Allergan Plc (AGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 63,503,972
  • Shares Outstanding, K 329,002
  • Annual Sales, $ 16,089 M
  • Annual Income, $ -5,271,000 K
  • 60-Month Beta 1.20
  • Price/Sales 3.95
  • Price/Cash Flow 5.26
  • Price/Book 1.09
Trade AGN with:
  • Price/Earnings ttm 10.94
  • Earnings Per Share ttm 17.64
  • Most Recent Earnings 5.22 on 02/10/20
  • Next Earnings Date 05/07/20
  • Annual Dividend & Yield 2.96 (0.00%)
  • Most Recent Dividend 0.740 on 04/15/20
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 4.24
  • Number of Estimates 1
  • High Estimate 4.24
  • Low Estimate 4.24
  • Prior Year 3.79
  • Growth Rate Est. (year over year) +11.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
181.21 +6.52%
on 04/09/20
196.45 -1.75%
on 05/06/20
+11.94 (+6.59%)
since 04/08/20
3-Month
158.67 +21.65%
on 03/18/20
202.21 -4.55%
on 02/12/20
-4.03 (-2.05%)
since 02/07/20
52-Week
114.27 +68.92%
on 06/17/19
202.21 -4.55%
on 02/12/20
+52.97 (+37.82%)
since 05/08/19

Most Recent Stories

More News
Evolus Deadline Alert

New York, New York--(Newsfile Corp. - October 20, 2020) - and would like to discuss your legal rights, click here or call Faruqi & Faruqi partner at or .

AGN : 193.02 (+0.02%)
EOLS : 3.93 (-6.21%)
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Evolus, Inc. (EOLS)

Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Evolus, Inc. ("Evolus" or the "Company") (NASDAQ: EOLS) in the United States District Court for the Southern District...

AGN : 193.02 (+0.02%)
EOLS : 3.93 (-6.21%)
Dermatological Therapeutics Market Share, Revenue, Regions And Top Key Players Analysis From 2020-2023 | Impact of COVID-19 Pandemic

Global Dermatological Therapeutics basically caters to three problems viz. cosmetics, skin cancer and general conditions such as Acne. Current analysis of the market shows huge demand and a lesser supply,...

AGN : 193.02 (+0.02%)
VRX.TO : 30.80 (-3.33%)
INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against Evolus, Inc.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Evolus, Inc. ("Evolus"...

AGN : 193.02 (+0.02%)
EOLS : 3.93 (-6.21%)
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allergan plc and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - October 19, 2020) -  , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allergan plc ("Allergan" or "the...

AGN : 193.02 (+0.02%)
AbbVie Announces Commencement of Registered Exchange Offers

, /PRNewswire/ -- ("AbbVie") announced today the commencement of its offers to exchange (the "Registered Exchange Offers") any and all of its outstanding (i) aggregate principal amount of senior unsecured...

ABBV : 84.25 (-0.07%)
AGN : 193.02 (+0.02%)
Aesthetic Devices Market Research Report by Product, by Material, by Gender, by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19

The Global is segmented on the lines of its technology, treatment, application and regional. Based on product type segmentation it covers Aesthetic Lasers, Ablative Lasers, Liposuction Devices of Other...

MMM : 170.95 (+0.83%)
AGN : 193.02 (+0.02%)
CYNO : 66.15 (+0.23%)
NSRGY : 117.4600 (+0.35%)
SIEN : 4.24 (+0.24%)
ELOS : 11.00 (unch)
VRX.TO : 30.80 (-3.33%)
ZLTQ : 56.48 (unch)
ZBH : 141.90 (-0.07%)
Acne Drugs Market Rising Demand, SWOT Analysis, Growth, Advanced Technologies and Trends | Allergan Plc, Nestle S.A. (Galderma S.A.)

has posted a newly modern statistical statistics, titled as Acne Drugs Market. It is a precious supply of and consists of correct data, which makes use of number one and secondary studies techniques....

AGN : 193.02 (+0.02%)
CSCO : 39.20 (-0.25%)
CTTAY : 12.0660 (+1.22%)
GSK : 36.04 (-0.39%)
NSRGY : 117.4600 (+0.35%)
PFE : 37.49 (-0.82%)
SIEGY : 71.6700 (+2.30%)
TEVA : 9.14 (-1.61%)
VRX.TO : 30.80 (-3.33%)
Medical Aesthetics Market Research: Growth Opportunities Regions, Types, Applications, Detail Research for Business Development

The Global is expected to exceed more than US$ 21.0 Billion by 2024 at a CAGR of 12% in the given forecast period.

AGN : 193.02 (+0.02%)
CYNO : 66.15 (+0.23%)
NSRGY : 117.4600 (+0.35%)
ELOS : 11.00 (unch)
VRX.TO : 30.80 (-3.33%)
ZLTQ : 56.48 (unch)
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Allergan plc Investors to Contact Firm Before Important October 29 Deadline in Class Action Seeking Recovery of Investor Losses; Encourages Investors with Losses in Excess of $500K to Contact the Firm - AGN

, /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Allergan plc (NYSE: AGN) between and , inclusive (the "Class Period"), of the important ...

AGN : 193.02 (+0.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan...

See More

Key Turning Points

2nd Resistance Point 194.42
1st Resistance Point 193.72
Last Price 193.02
1st Support Level 191.98
2nd Support Level 190.94

See More

52-Week High 202.21
Last Price 193.02
Fibonacci 61.8% 168.62
Fibonacci 50% 158.24
Fibonacci 38.2% 147.86
52-Week Low 114.27

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar